150 participants
Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2026-07-31
- Start Date:
- 2023-01-01
- Completion:
- 2025-11-30
Conditions
- Ulcerative Colitis (UC)
Interventions
- DRUG
No Results Yet